250 related articles for article (PubMed ID: 30156539)
1. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
[TBL] [Abstract][Full Text] [Related]
2. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
Retamozo S; Acar-Denizli N; Rasmussen A; Horváth IF; Baldini C; Priori R; Sandhya P; Hernandez-Molina G; Armagan B; Praprotnik S; Kvarnstrom M; Gerli R; Sebastian A; Solans R; Rischmueller M; Pasoto SG; Valim V; Nordmark G; Kruize A; Nakamura H; Hofauer B; Giacomelli R; Fernandes Moça Trevisani V; Devauchelle-Pensec V; Atzeni F; Gheita TA; Consani-Fernández S; Szántó A; Sivils K; Gattamelata A; Danda D; Kilic L; Bartoloni E; Bombardieri S; Sánchez-Guerrero J; Wahren-Herlenius M; Mariette X; Ramos-Casals M; Brito-Zerón P;
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):97-106. PubMed ID: 31464664
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
4. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
Acar-Denizli N; Horváth IF; Mandl T; Priori R; Vissink A; Hernandez-Molina G; Armagan B; Praprotnik S; Sebastian A; Bartoloni E; Rischmueller M; Pasoto SG; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Retamozo S; Carsons SE; Maure-Noia B; Sánchez-Berná I; López-Dupla M; Fonseca-Aizpuru E; Melchor Díaz S; Vázquez M; Díaz Cuiza PE; de Miguel Campo B; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Seror R; Gottenberg JE; Kruize AA; Sandhya P; Gandolfo S; Kwok SK; Kvarnstrom M; Solans R; Sene D; Suzuki Y; Isenberg DA; Valim V; Hofauer B; Giacomelli R; Devauchelle-Pensec V; Atzeni F; Gheita TA; Morel J; Izzo R; Kalyoncu U; Szántó A; Olsson P; Bootsma H; Ramos-Casals M; Kostov B; Brito-Zerón P;
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):85-94. PubMed ID: 33095152
[TBL] [Abstract][Full Text] [Related]
5. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.
Brito-Zerón P; Kostov B; Solans R; Fraile G; Suárez-Cuervo C; Casanovas A; Rascón FJ; Qanneta R; Pérez-Alvarez R; Ripoll M; Akasbi M; Pinilla B; Bosch JA; Nava-Mateos J; Díaz-López B; Morera-Morales ML; Gheitasi H; Retamozo S; Ramos-Casals M;
Ann Rheum Dis; 2016 Feb; 75(2):348-55. PubMed ID: 25433020
[TBL] [Abstract][Full Text] [Related]
6. How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
Brito-Zerón P; Gheitasi H; Retamozo S; Bové A; Londoño M; Sánchez-Tapias JM; Caballero M; Kostov B; Forns X; Kaveri SV; Ramos-Casals M
Arthritis Res Ther; 2015 Sep; 17(1):250. PubMed ID: 26370711
[TBL] [Abstract][Full Text] [Related]
7. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
Anquetil C; Hachulla E; Machuron F; Mariette X; Le Guern V; Vittecoq O; Dernis E; Larroche C; Dubost JJ; Perdriger A; Devauchelle-Pensec V; Fauchais AL; Morel J; Dieudé P; Rist S; Sene D; Gottenberg JE; Hatron PY
Rheumatology (Oxford); 2019 Jul; 58(7):1163-1167. PubMed ID: 30561748
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
9. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.
Brito-Zerón P; Acar-Denizli N; Zeher M; Rasmussen A; Seror R; Theander E; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Kruize AA; Valim V; Kvarnstrom M; Sene D; Gerli R; Praprotnik S; Isenberg D; Solans R; Rischmueller M; Kwok SK; Nordmark G; Suzuki Y; Giacomelli R; Devauchelle-Pensec V; Bombardieri M; Hofauer B; Bootsma H; Brun JG; Fraile G; Carsons SE; Gheita TA; Morel J; Vollenveider C; Atzeni F; Retamozo S; Horvath IF; Sivils K; Mandl T; Sandhya P; De Vita S; Sanchez-Guerrero J; van der Heijden E; Trevisani VFM; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
Ann Rheum Dis; 2017 Jun; 76(6):1042-1050. PubMed ID: 27899373
[TBL] [Abstract][Full Text] [Related]
10. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
Bodakçi E
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
[TBL] [Abstract][Full Text] [Related]
12. Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.
Retamozo S; Acar-Denizli N; Horváth IF; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Olsson P; Priori R; Seror R; Gottenberg JE; Kruize AA; Hernandez-Molina G; Vissink A; Sandhya P; Armagan B; Quartuccio L; Sebastian A; Praprotnik S; Bartoloni E; Kwok SK; Kvarnstrom M; Rischmueller M; Soláns-Laqué R; Sene D; Pasoto SG; Suzuki Y; Isenberg DA; Valim V; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Hofauer B; Sisó-Almirall A; Giacomelli R; Devauchelle-Pensec V; Bombardieri M; Atzeni F; Hammenfors D; Maure B; Carsons SE; Gheita T; Sánchez-Berná I; López-Dupla M; Morel J; Inanç N; Fonseca-Aizpuru E; Morcillo C; Vollenweider C; Melchor S; Vázquez M; Díaz-Cuiza E; Consani-Fernández S; de-Miguel-Campo B; Szántó A; Bombardieri S; Gattamelata A; Hinrichs A; Sánchez-Guerrero J; Danda D; Kilic L; De Vita S; Wiland P; Gerli R; Park SH; Wahren-Herlenius M; Bootsma H; Mariette X; Ramos-Casals M; Brito-Zerón P;
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):166-174. PubMed ID: 34919044
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
[TBL] [Abstract][Full Text] [Related]
14. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients.
Maślińska M; Mańczak M; Kwiatkowska B
Clin Rheumatol; 2019 May; 38(5):1301-1307. PubMed ID: 30810912
[TBL] [Abstract][Full Text] [Related]
16. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
17. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.
Brito-Zerón P; Flores-Chávez A; Horváth IF; Rasmussen A; Li X; Olsson P; Vissink A; Priori R; Armagan B; Hernandez-Molina G; Praprotnik S; Quartuccio L; Inanç N; Özkızıltaş B; Bartoloni E; Sebastian A; Romão VC; Solans R; Pasoto SG; Rischmueller M; Galisteo C; Suzuki Y; Trevisani VFM; Fugmann C; González-García A; Carubbi F; Jurcut C; Shimizu T; Retamozo S; Atzeni F; Hofauer B; Melchor-Díaz S; Gheita T; López-Dupla M; Fonseca-Aizpuru E; Giacomelli R; Vázquez M; Consani S; Akasbi M; Nakamura H; Szántó A; Farris AD; Wang L; Mandl T; Gattamelata A; Kilic L; Pirkmajer KP; Abacar K; Tufan A; de Vita S; Bootsma H; Ramos-Casals M;
EClinicalMedicine; 2023 Jul; 61():102062. PubMed ID: 37457113
[TBL] [Abstract][Full Text] [Related]
18. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
Ter Borg EJ; Kelder JC
Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
20. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
Ramos-Casals M; Maria A; Suárez-Almazor ME; Lambotte O; Fisher BA; Hernández-Molina G; Guilpain P; Pundole X; Flores-Chávez A; Baldini C; Bingham Iii CO; Brito-Zerón P; Gottenberg JE; Kostine M; Radstake TRD; Schaeverbeke T; Schulze-Koops H; Calabrese L; Khamashta MA; Mariette X;
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):114-122. PubMed ID: 31464670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
